Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Intermediate I. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101225063A details a novel alkaline hydrolysis route for Cysteamine Hydrochloride, offering higher yields, shorter cycles, and enhanced safety for API manufacturing.
Patent CN101429199B details a mild two-step racemization process for fluoroquinolone intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN111116531A reveals a novel one-step hydrogenation method for Ramelteon intermediates, offering superior purity and safer processing for pharmaceutical manufacturing.
Patent CN112442474B reveals a robust Fusarium oxysporum lactamase for optically pure (-) gamma-lactam production, offering superior stability and cost-effective manufacturing solutions.
Novel 1-aza-5-germanocarbobicyclo[3.3.3]undecane synthesis via patent CN112194674B. Stable air-tolerant intermediates for advanced material manufacturing.
Advanced preparation of Maropitant intermediates via transition metal catalysis. High purity, >99% ee, and scalable routes for pharmaceutical manufacturing.
Patent CN102391243A details a novel 7-step synthesis for Atorvastatin intermediates, eliminating expensive lithium reagents and improving supply chain reliability.
Patent CN114437089A reveals a safer, high-yield route for Nalfurafine intermediate NAHY-2 using formic acid transfer hydrogenation, offering significant cost and supply chain advantages.
Patent CN113354599A reveals a safer, high-yield route for Nintedanib key intermediates using hydrazine reduction, offering significant cost reduction in API manufacturing.
Patent CN116217426B details a novel SN2 inversion route for S-fluobutyramide. This method offers significant cost reduction and supply chain reliability for agrochemical manufacturing.
Patent CN108101841B details a controlled hydrogenation method for Indacaterol, significantly reducing Impurity A and enhancing manufacturing efficiency for global supply chains.
Patent CN111349014A reveals a safer, high-yield route for Methyl (methylamino)squarate, eliminating hazardous solvents and reducing manufacturing costs for global supply chains.
Patent CN110143973B reveals a novel inorganic salt salification process for Flomoxef Sodium, eliminating organic acid residues and ensuring superior stability for pharmaceutical manufacturing.
Novel patent CN120842228A offers high-yield synthesis for HIV and JAK inhibitor intermediates, ensuring cost reduction and supply chain reliability for global manufacturers.
Patent CN104080791B details CO2 isolation for boronates. Enhances purity and solvent recovery for scalable agrochemical intermediate supply chains.
Advanced synthesis of Nafcillin Sodium Hydrate via optimized ethylation and coupling. Delivers high purity >99.5% and reduced solvent residuals for pharmaceutical manufacturing.
Patent CN118125928B reveals a high-purity synthesis route. Achieve significant cost reduction and supply chain reliability for ambroxol intermediates.
Patent CN112079708A reveals a mild radical coupling route for octadecanedioic acid. Achieve >98.5% purity with reduced costs for polymer and pharma applications.
Patent CN110862363B reveals a green route for furanylaldehydes using heterogeneous Mn catalysts, offering high selectivity and cost reduction for pharma intermediates.
Patent CN103613521A details a water-phase synthesis for Probenecid. This method eliminates heavy metals and organic solvents, offering significant supply chain and cost advantages.